The Achilles Heel of Clostridioides difficile Infection?

Katia Fettucciari,Andrea Spaterna,Pierfrancesco Marconi,Gabrio Bassotti
DOI: https://doi.org/10.3390/ijms25020958
IF: 5.6
2024-01-13
International Journal of Molecular Sciences
Abstract:Bacterial infections are characterized by an inflammatory response, which is essential for infection containment but is also responsible for negative effects on the host. The pathogen itself may have evolved molecular mechanisms to antagonize the antimicrobial effects of an inflammatory response and to enhance its pathogenicity using inflammatory response mediators, such as cytokines. Clostridioides difficile (C. difficile) infection (CDI) causes gastrointestinal diseases with markedly increasing global incidence and mortality rates. The main C. difficile virulence factors, toxin A and B (TcdA/TcdB), cause cytopathic/cytotoxic effects and inflammation. We previously demonstrated that TcdB induces enteric glial cell (EGC) apoptosis, which is enhanced by the pro-inflammatory cytokine tumor necrosis factor alpha plus interferon gamma (CKs). However, it is unknown whether CKs-enhanced TcdB cytotoxicity (apoptosis/necrosis) is affected by the timing of the appearance of the CKs. Thus, we simulated in vitro, in our experimental model with TcdB and EGCs, three main situations of possible interactions between TcdB and the timing of CK stimulation: before TcdB infection, concomitantly with infection, or at different times after infection and persisting over time. In these experimental conditions, which all represent situations of possible interactions between C. difficile and the timing of CK stimulation, we evaluated apoptosis, necrosis, and cell cycle phases. The CKs, in all of these conditions, enhanced TcdB cytotoxicity, which from apoptosis became necrosis when CK stimulation persisted over time, and was most relevant after 48 h of TcdB:EGCs interaction. Particularly, the enhancement of apoptosis by CKs was dependent on the TcdB dose and in a less relevant manner on the CK stimulation time, while the enhancement of necrosis occurred always independently of the TcdB dose and CK stimulation time. However, since in all conditions stimulation with CKs strongly enhanced the TcdB cytotoxicity, it always had a negative impact on C. difficile pathogenicity. This study might have important implications for the treatment of CDI.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to explore the effects of pro - inflammatory cytokines (such as tumor necrosis factor - α and interferon - γ) on the cytotoxic activity of Clostridioides difficile toxin B (TcdB) in enteric glial cells (EGCs) at different time points. Specifically, the researchers simulated three main situations to evaluate how pro - inflammatory cytokines enhance the cytotoxicity of TcdB in these situations: 1. **Inflammatory state prior to infection**: - Simulation object: Hosts ranging from a low - level inflammatory state to a high - level inflammatory state (such as patients with inflammatory bowel disease). - Experimental design: Pretreat EGCs 18 hours or 2 hours before TcdB treatment (protocols A and B in Figure 2). 2. **Inflammatory response at the start of infection**: - Simulation object: The situation where the host immediately has an inflammatory response at the start of infection. - Experimental design: Treat EGCs with TcdB and cytokines simultaneously, or add cytokines 1.5 hours after TcdB treatment (protocols C and D in Figure 2). 3. **Inflammatory response gradually becomes significant after infection**: - Simulation object: Hosts with a gradually increasing inflammatory response after infection. - Experimental design: (I) Add cytokines 48 hours after TcdB treatment and continue the treatment for 24 hours or 48 hours (protocol E in Figure 2); (II) Add cytokines 1.5 hours after TcdB treatment and continue the treatment for 24 hours, 48 hours, or 72 hours (protocols F and G in Figure 2). Through these experimental designs, the researchers hope to understand the effects of pro - inflammatory cytokines on TcdB cytotoxicity (including apoptosis and necrosis) at different time points, thereby providing a new perspective for understanding the pathophysiological mechanisms of CDI and potential new methods for treating CDI.